Alpha-bisabolol for Onychomycosis Treatment

Status Completed

Clinical Trial Summary

Clinical, interventional, longitudinal study with random sampling. 60 patients will be divided into three groups, group A: control group, drug recommended by the Brazilian Society of Dermatology, group B: alpha bisabolol-based product associated with low-level laser therapy, and group C: alpha bisabolol based product. The topical application will be performed twice a day, while the laser application and photographs of the lesions, every 15 days. Areas of the lesions will be compared.

Clinical Trial Description

Introduction: Onychomycosis is an infection caused by fungi that feed on keratin, a protein that makes up most of the nails. In patients with diabetes mellitus and onychomycosis, the risk of foot complications is a concern, especially for those who do not perform the practice of self-care of the skin, nails and feet in general correctly, which can trigger an important tissue damage that culminates in limb amputation. One of the alternatives for the treatment are herbal medicines. The application of alpha-bisabolol in the pharmaceutical sector is related to its anti-inflammatory, antispasmodic, antiallergic, drug permeation and deworming properties, having an important action in the morphology of dermatophytic fungal cells. Objectives: Develop and evaluate a pharmaceutical formula with alpha-bisololol for the treatment of onychomycosis. Methods: Clinical, interventional, longitudinal study with random sampling. The study will be held at the Sthomatherapy Clinic of the Nursing Care and Teaching Center at the Samuel Libânio Hospital and at the DermatoCare Clinic Stomatherapy and Podiatry Clinic, Pouso Alegre, MG. 60 patients with onychomycosis will participate in this study, which will be divided into three groups, group A: control group, drug recommended by the Brazilian Society of Dermatology, group B: alpha bisabolol-based product associated with low-level laser therapy, and group C: alpha bisabolol based product. The topical application will be performed twice a day, while the laser application and photographs of the lesions, every 15 days. ;

Study Design

Related Conditions & MeSH terms

Onychomycosis

Clinical Trial Details

NCT number	NCT04940520
Study type	Interventional
Source	Universidade do Vale do Sapucai
Contact
Status	Completed
Phase	Phase 1
Start date	June 1, 2020
Completion date	May 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03098615` - Study Evaluating the Effect of Jublia on Dermatophytomas	Phase 4
Recruiting	`NCT01666002` - Treatment of Onychomycosis Using a 0.65 Millisecond Pulsed Nd:YAG 1064 nm Laser	N/A
Completed	`NCT01180491` - A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis	N/A
Terminated	`NCT01208129` - Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Phase 3
Terminated	`NCT01208168` - Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails	Phase 3
Completed	`NCT00385502` - A Trial of the Safety and Efficacy of EcoNail™ in the Treatment of Fungus Infections of the Great Toenail	Phase 2
Completed	`NCT00253305` - Topical Gel Anti-Fungal Agent for Tinea Unguium	Phase 2
Not yet recruiting	`NCT05809297` - Diode Laser and Photodynamic Therapy Vs. Ciclopirox.	Phase 4
Completed	`NCT03405818` - An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents	Phase 4
Completed	`NCT02588599` - A Retrospective Analysis of the Effects of Low Level Laser Therapy on Toenail Onychomycosis	N/A
Recruiting	`NCT02436291` - Evaluation of the Efficacy of CURE-EX Treatment in Onychomycosis	Phase 4
Completed	`NCT01851590` - Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis	Phase 4
Completed	`NCT01452490` - Diode Laser Treatment of Onychomycosis	N/A
Withdrawn	`NCT00938925` - Effectiveness of Podiatry Care on Onychomycosis (EPOCAON)	N/A
Recruiting	`NCT00808366` - Efficacy and Safety of RV4104A Ointment in Onychomycosis	N/A
Completed	`NCT00781820` - Comparative Efficacy of Bifonazole Cream vs Placebo After Nail Ablation With Urea Paste	Phase 3
Completed	`NCT00768768` - Iontophoretic Application of Terbinafine Gel to the Large Toe Nail	Phase 1
Completed	`NCT00777868` - A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis	Phase 2
Recruiting	`NCT06074315` - Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis	N/A
Completed	`NCT01039883` - A Study to Compare the Blood Levels of Albaconazole in Healthy Subjects Who Have Received a Single Dose of 400 mg Albaconazole as a Tablet Versus Albaconazole as a Capsule	Phase 1